Skip to main content

CRISPR stocks tank after research shows edited cells might cause cancer

The new research could pose a major setback to the treatment that has has been hailed as a breakthrough.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.